Novelwise Pharmaceutical Corporation
3 clinical trials · Sponsor
◉ Watch Novelwise Pharmaceutical Corporation
| Record | Firm | Date |
|---|---|---|
| A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT07569042) | Novelwise Pharmaceutical Corporation | 2026-04-20 |
| Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma (NCT07136181) | Novelwise Pharmaceutical Corporation | 2025-11-20 |
| NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma (NCT06012695) | Novelwise Pharmaceutical Corporation | 2023-08-11 |
Track Novelwise Pharmaceutical Corporation automatically
Every clearance here is in the API, with alerts when new ones post.